Publications by authors named "Ilan Vavilin"
Article Synopsis
- Cardiogenic shock (CS) is a serious condition with various causes and can lead to high rates of illness and death (35-50%), even with modern treatments.
- Recent research has focused on better recognition and management of CS through standardized protocols and tailored use of temporary mechanical support, which have shown promising results.
- This review covers the underlying mechanisms of CS, emerging definitions and treatment strategies, and highlights the need for more studies to fill knowledge gaps and improve patient outcomes.
The Impella mechanical circulatory support (MCS) system is a catheter-based continuous flow cardiac assist device that is widely used in the treatment of cardiogenic shock in medical and surgical cardiac intensive care units. As with all forms of MCS, device-related complications remain a major concern, the incidence of which can be mitigated by adhering to a few fundamental concepts in device management. The purpose of this review is to comprehensively describe our strategy for managing, repositioning, and weaning the Impella catheter.
View Article and Find Full Text PDFBiologic therapy has revolutionized the management of chronic inflammatory diseases, including inflammatory bowel disease (IBD). Before the initiation of therapy, it is critical to rule out prior infection of chronic hepatitis B virus (HBV) and tuberculosis (TB). However, screening for human immunodeficiency virus (HIV) is not as routinely completed.
View Article and Find Full Text PDFImplications of Misclassification of Type 2 Myocardial Infarction on Clinical Outcomes.
Cardiovasc Revasc Med
February 2020
Background: Patients with type 2 myocardial infarction (MI) are often classified under the diagnosis of non-ST-segment-elevation MI (NSTEMI) despite the significant differences in clinical characteristics, management, and outcomes between type 2 MI and type 1 NSTEMI. This may have significant implications that can lead to inaccurate assessment of quality measures by MI quality review programs.
Methods: A single-center retrospective study of 1224 patients discharged with the diagnosis of type 1 NSTEMI between January 2015 and September 2017.
Left atrial fibrous band is a rare clinical and echocardiographic finding characterized by the presence of a fibrous band attached to the mitral valve. Diagnosis is accomplished with transesophageal echocardiography (TEE), live 3D imaging, or cardiac MRI. Most patients are asymptomatic and incidental findings.
View Article and Find Full Text PDF